ANTIPODES PARTNERS Ltd raised its stake in shares of LyondellBasell Industries N.V. (NYSE:LYB - Free Report) by 20.0% during the 1st quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor owned 109,341 shares of the specialty chemicals company's stock after purchasing an additional 18,201 shares during the period. ANTIPODES PARTNERS Ltd's holdings in LyondellBasell Industries were worth $7,698,000 at the end of the most recent quarter.
Several other hedge funds and other institutional investors have also added to or reduced their stakes in the stock. Lifeworks Advisors LLC lifted its holdings in LyondellBasell Industries by 71.7% during the first quarter. Lifeworks Advisors LLC now owns 56,623 shares of the specialty chemicals company's stock valued at $3,986,000 after purchasing an additional 23,638 shares in the last quarter. Journey Strategic Wealth LLC lifted its stake in shares of LyondellBasell Industries by 46.3% in the first quarter. Journey Strategic Wealth LLC now owns 8,264 shares of the specialty chemicals company's stock worth $582,000 after buying an additional 2,615 shares in the last quarter. Pinnacle Associates Ltd. lifted its stake in shares of LyondellBasell Industries by 30.8% in the first quarter. Pinnacle Associates Ltd. now owns 30,817 shares of the specialty chemicals company's stock worth $2,170,000 after buying an additional 7,263 shares in the last quarter. Unison Advisors LLC lifted its stake in shares of LyondellBasell Industries by 1.7% in the first quarter. Unison Advisors LLC now owns 41,267 shares of the specialty chemicals company's stock worth $2,905,000 after buying an additional 703 shares in the last quarter. Finally, Abel Hall LLC purchased a new position in shares of LyondellBasell Industries in the first quarter worth about $267,000. 71.20% of the stock is owned by hedge funds and other institutional investors.
LyondellBasell Industries Trading Up 5.5%
Shares of LyondellBasell Industries stock traded up $3.36 on Friday, reaching $64.06. The company had a trading volume of 5,730,012 shares, compared to its average volume of 3,417,836. The firm's 50 day moving average price is $59.95 and its two-hundred day moving average price is $65.86. The firm has a market cap of $20.59 billion, a PE ratio of 19.77, a PEG ratio of 3.41 and a beta of 0.82. LyondellBasell Industries N.V. has a 52-week low of $51.11 and a 52-week high of $100.46. The company has a debt-to-equity ratio of 0.87, a quick ratio of 1.04 and a current ratio of 1.83.
LyondellBasell Industries (NYSE:LYB - Get Free Report) last announced its quarterly earnings data on Friday, April 25th. The specialty chemicals company reported $0.33 earnings per share for the quarter, missing analysts' consensus estimates of $0.36 by ($0.03). The business had revenue of $7.68 billion during the quarter, compared to analyst estimates of $7.69 billion. LyondellBasell Industries had a net margin of 2.81% and a return on equity of 13.19%. The company's revenue for the quarter was down 7.6% on a year-over-year basis. During the same quarter last year, the firm posted $1.53 EPS. Sell-side analysts predict that LyondellBasell Industries N.V. will post 6.31 earnings per share for the current fiscal year.
LyondellBasell Industries Increases Dividend
The firm also recently disclosed a quarterly dividend, which was paid on Monday, June 9th. Investors of record on Monday, June 2nd were issued a $1.37 dividend. The ex-dividend date of this dividend was Monday, June 2nd. This represents a $5.48 dividend on an annualized basis and a dividend yield of 8.56%. This is a boost from LyondellBasell Industries's previous quarterly dividend of $1.34. LyondellBasell Industries's payout ratio is 169.14%.
Analysts Set New Price Targets
Several equities analysts have recently weighed in on the stock. Wells Fargo & Company raised their price target on shares of LyondellBasell Industries from $70.00 to $75.00 and gave the stock an "overweight" rating in a research note on Monday, July 14th. Mizuho raised their price target on shares of LyondellBasell Industries from $65.00 to $67.00 and gave the stock a "neutral" rating in a research note on Tuesday, July 15th. Piper Sandler decreased their price target on shares of LyondellBasell Industries from $67.00 to $66.00 and set a "neutral" rating on the stock in a research note on Thursday, May 1st. Argus downgraded shares of LyondellBasell Industries from a "buy" rating to a "hold" rating in a research note on Friday, May 30th. Finally, Citigroup reduced their target price on shares of LyondellBasell Industries from $58.00 to $56.00 in a research note on Wednesday, June 11th. Three analysts have rated the stock with a sell rating, ten have assigned a hold rating, two have issued a buy rating and one has assigned a strong buy rating to the stock. According to MarketBeat.com, the company has an average rating of "Hold" and a consensus target price of $66.00.
View Our Latest Report on LYB
About LyondellBasell Industries
(
Free Report)
LyondellBasell Industries N.V. operates as a chemical company in the United States, Germany, Mexico, Italy, Poland, France, Japan, China, the Netherlands, and internationally. The company operates in six segments: Olefins and PolyolefinsAmericas; Olefins and PolyolefinsEurope, Asia, International; Intermediates and Derivatives; Advanced Polymer Solutions; Refining; and Technology.
Further Reading

Before you consider LyondellBasell Industries, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and LyondellBasell Industries wasn't on the list.
While LyondellBasell Industries currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Market downturns give many investors pause, and for good reason. Wondering how to offset this risk? Enter your email address to learn more about using beta to protect your portfolio.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.